bioRxivCancer BiologyPreprint
Heterogeneous and conserved radiation responses reveal FOXM1-dependent regulation of microcephaly genes in glioblastoma
Lou Van EupeniD, Emre EtliogluiD, Kevin TaburyiD, Keith Lloyd LigoniD, Rosa AguirreiD, Marleen DerweduweiD, A. Claeys, Anggraeini Puspitasari-KokkoiD, Irina PrimaciD, Frederik De SmetiD, Roel QuintensiD
- Citations
- 0
Abstract
Glioblastoma (GBM) is characterized by marked heterogeneity, glioma stem-like cells (GSCs), and resistance to therapy. Because GSCs share features with neural progenitor cells (NPCs), we investigated whether neurodevelopmental programs contribute to their response to irradiation. Transcriptional profiling of four patient-derived GSC lines revealed cell line-specific responses, with radiosensitivity correlating with the magnitude of p53 activation and basal expression of its negative regulator, MDM2. Despite this heterogeneity, radiation consistently activated p53-dependent pathways and suppressed cell-cycle programs. Among these, genes associated with primary hereditary microcephaly (MCPH) that regulate NPC proliferation were coordinately repressed. Single-cell RNA sequencing localized this response to G2/M-cycling cells. FOXM1 was similarly reduced following irradiation, emerged as a candidate regulator of a subset of MCPH genes, and correlated with their expression in GBM tumors. Pharmacological inhibition of FOXM1 reduced expression of selected MCPH genes and enhanced radiosensitivity in U251 cells. Together, these findings identify coordinated suppression of a FOXM1-associated MCPH program as part of the GBM radiation response, while suggesting that the radiosensitizing effects of pharmacological FOXM1 inhibition extend beyond this transcriptional axis.
- organism: human
- assay: scRNA-seq
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate target genes to improve treatment outcomes
S. Choudhary, S. C. Burns, … L. O. Penalva·bioRxiv·Dec 5, 2019
- BRD9 inhibition induces selective radiosensitivity in glioblastoma through MYC pathway modulation
Nareg Pinarbasi Degirmenci, S A Celikkol, … Tugba Bagci Onder·bioRxiv·Aug 11, 2026
- BCL6 is a context-dependent mediator of the glioblastoma response to irradiation therapy
A. Tribe, L. Peng, … M. J. McConnell·bioRxiv·May 29, 2023
- Radiosensitization of Glioblastoma by the K-ras Inhibitor RMC-6236
Hong Shik Yun, Tamalee R. Kramp, … Kevin A. Camphausen·bioRxiv·Jun 2, 2026
- Chronically radiation-exposed survivor glioblastoma cells display poor response to Chk1 inhibition
N. Pinarbasi Degirmenci, I. Sur-Erdem, … T. Bagci-Onder·bioRxiv·Apr 16, 2022
- The Dopamine Receptor Antagonist TFP Prevents Phenotype Conversion and Improves Survival in Mouse Models of Glioblastoma
Kruttika Bhat, Mohammad Saki, … Frank Pajonk·Proceedings of the National Academy of SciencesPeer-reviewed·May 1, 2020